NMR Structure of Temporin-1 Ta in Lipopolysaccharide Micelles: Mechanistic Insight into Inactivation by Outer Membrane

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Saravanan, Rathi ^a   Joshi, Mangesh ^a   Mohanram, Harini ^a   Bhunia, Anirban ^a   Mangoni, Maria Luisa ^b   Bhattacharjya, Surajit ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TEMPORIN 1 TA; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; ESCHERICHIA COLI; MEMBRANE PERMEABILITY; MICELLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN MULTIMERIZATION; PROTEINS; SOLUTIONS; STATIC ELECTRICITY;

EID: 84883622438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072718     Document Type: Article

References (67)

1. Hancock RE, (1997) Peptide antibiotics. Lancet 349: 418-422.
2. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
3. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
4. Jenssen H, Hamill P, Hancock RE, (2006) Peptide antimicrobial agents. Clin Microbiol Rev19: 491-511.
5. Nicolas P, (2009) Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J. 276: 6483-6496.
6. Auvynet C, Rosenstein Y, (2009) Multifunctional host defense peptides: Antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 276: 6497-6508.
7. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM, (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135: 1-11.
8. Oyston PC, Fox MA, Richards SJ, Clark GC, (2009) Novel peptide therapeutics for treatment of infections. J Med Microbiol 58: 977-987.
9. Epand RM, Vogel HJ, (1999) Diversity of antimicrobial peptides and their mechanisms of action, Biochim Biophys Acta. 1462: 11-28.
10. Shai Y, (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248.
11. Nguyen LT, Haney EF, Vogel HJ, (2011) The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol. 29: 464-472.
12. Wimley WC, (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5: 905-917.
13. Nikaido H, (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67: 593-656.
14. Snyder DS, McIntosh TJ, (2000) The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics. Biochemistry 39: 11777-11787.
15. Bhattacharjya S, Ramamoorthy A, (2009) Multifunctional host defense peptides: functional and mechanistic insights from NMR structures of potent antimicrobial peptides. FEBS J. 276: 6465-6473.
16. Yount NY, Yeaman MR, (2013) Peptide antimicrobials: cell wall as a bacterial target. Ann N Y Acad Sci 1277: 127-138.
17. Ding L, Yang L, Weiss TM, Waring AJ, Lehrer RI, et al. (2003) Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 42: 12251-12259.
18. Papo N, Shai Y, (2005) A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. J Biol. Chem. 280: 10378-10387.
19. Bhattacharjya S, (2010) De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs. Curr Med Chem 17: 3080-3093.
20. Srivastava RM, Srivastava S, Singh M, Bajpai VK, Ghosh JK, (2012) Consequences of alteration in leucine zipper sequence of melittin in its neutralization of lipopolysaccharide-induced proinflammatory response in macrophage cells and interaction with lipopolysaccharide. J Biol Chem 287: 1980-1995.
21. Raetz CR, Whitfield C, (2002) Lipopolysaccharide endotoxin. Annu Rev Biochem 71: 635-700.
22. Hancock RE, (1984) Alterations in outer membrane permeability. Annu Rev Microbiol 38: 237-264.
23. Bhunia A, Ramamoorthy A, Bhattacharjya S, (2009) Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy. Chemistry 15: 2036-2040.
24. Japelj B, Pristovsek P, Majerle A, Jerala R, (2005) Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J Biol Chem 280: 16955-16961.
25. Bhunia A, Mohanram H, Domadia PN, Torres J, Bhattacharjya S, (2009) Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide. J Biol Chem 284: 21991-22004.
26. Bhattacharjya S, Domadia PN, Bhunia A, Malladi S, David SA, (2007) High resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity and anti-endotoxic activity. Biochemistry 46: 5864-5874.
27. Bhunia A, Domadia P, Torres J, Hallock KJ, Ramamoorthy A, et al. (2010) NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem 285: 3883-3895.
28. Beutler B, Rietschel ET, (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176.
29. Ward PA, (2004) The dark side of C5a in sepsis. Nat Rev Immunol 4: 133-142.
30. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
31. Angus DC, Wax RS, (2001) Epidemiology of sepsis: an update. Crit Care Med 29: S109-S116.
32. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
33. Miller SI, Ernst RK, Bader MW, (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
34. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR, (2000) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164: 549-553.
35. Azmi S, Srivastava S, Mishra NN, Tripathi JK, Shukla PK, et al. (2013) Characterization of antimicrobial, cytotoxic, and antiendotoxin properties of short peptides with different hydrophobic amino acids at "a" and "d" positions of a heptad repeat sequence. J Med Chem. 56: 924-939.
36. Mangoni ML, (2006) Temporins, anti-infective peptides with expanding properties. Cell Mol Life Sci 63: 1060-1069.
37. Mangoni ML, Shai Y, (2009) Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification. Biochim Biophys Acta 1788: 1610-1619.
38. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, et al. (2006) Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob Agents Chemother 50: 2478-2486.
39. Rosenfeld Y, Barra D, Simmaco M, Shai Y, Mangoni ML, (2006) A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J Biol Chem 281: 28565-28574.
40. Mangoni ML, Epand RF, Rosenfeld Y, Peleg A, Barra D, et al. (2008) Lipopolysaccharide, a key molecule involved in the synergism between temporins in inhibiting bacterial growth and in endotoxin neutralization. J Biol Chem 283: 22907-22917.
41. Bhunia A, Saravanan R, Mohanram H, Mangoni ML, Bhattacharjya S, (2011) NMR structures and interactions of temporin-1Tl and temporin-1Tb with lipopolysaccharide micelles: mechanistic insights into outer membrane permeabilization and synergistic activity. J. Biol Chem 286: 24394-24406.
42. Grieco P, Carotenuto A, Auriemma L, Saviello MR, Campiglia P, et al. (2013) The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-candida peptide, Biochim Biophys. Acta1828: 652-660.
43. Wang C, Tian LL, Li S, Li HB, Zhou Y, et al. (2013) Rapid cytotoxicity of antimicrobial peptide tempoprin-1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism. PLoS One. 8: e60462.
44. Grieco P, Luca V, Auriemma L, Carotenuto A, Saviello MR, et al. (2011) Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. J Pept Sci 17: 358-365.
45. Mangoni ML, Carotenuto A, Auriemma L, Saviello MR, Campiglia P, et al. (2011) Structure-activity relationship, conformational and biological studies of temporin L analogues, J Med Chem. 54: 1298-12307.
46. Capparelli R, Romanelli A, Iannaccone M, Nocerino N, Ripa R, et al. (2009) Synergistic antibacterial and anti-inflammatory activity of temporin A and modified temporin B in vivo. PLoS One 4: e7191.
47. Simonetti O, Cirioni O, Goteri G, Ghiselli R, Kamysz W, et al. (2008) Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model (2008) Peptides. 4: 520-528.
48. Rinaldi AC, Mangoni ML, Rufo A, Luzi C, Barra D, et al. (2002) Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J. 368: 91-100.
49. Clore GM, Gronenborn AM, (1982) Theory and applications of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J Magn Reson 48: 402-417.
50. Post CB, (2003) Exchange-transferred NOE spectroscopy and bound ligand structure determination. Curr Opin Struct Biol 13: 581-588.
51. Yu L, Tan M, Ho B, Ding JL, Wohland T, (2006) Determination of critical micelle concentrations and aggregation numbers by fluorescence correlation spectroscopy: aggregation of a lipopolysaccharide. Anal Chim Acta 556: 216-225.
52. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, et al. (2002) The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277: 8279-8289.
53. Saravanan R, Bhattacharjya S, (2011) Oligomeric structure of a cathelicidin antimicrobial peptide in dodecylphosphocholine micelle determined by NMR spectroscopy. BBA (biomembrane) 1808: 369-381.
54. Mani R, Cady SD, Tang M, Waring AJ, Lehrer RI,et al. (2006) Membrane dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci USA:103 16242-16247.
55. Porcelli F, Buck-Koehntop BA, Thennarasu S, Ramamoorthy A, Veglia G, (2006) Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry 45: 5793-5799.
56. Bhunia A, Bhattacharjya S, (2011) Mapping residue specific contacts of polymyxin B with lipopolysaccharide by saturation transfer difference NMR: insight into outer-membrane disruption and endotoxin neutralization. Biopolymers (Peptide Science) 96: 273-287.
57. Mangoni ML, Shai Y, (2011) Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action. Cell Mol Life Sci 68: 2267-2280.
58. Mangoni ML, Maisetta G, Di Luca M, Gaddi LM, Esin S, et al. (2008) Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother 52: 85-91.
59. Carotenuto A, Malfi S, Saviello MR, Campiglia P, Gomez-Monterrey I, et al. (2008) A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. J Med Chem. 51: 2354-2362.
60. Saviello MR, Malfi S, Campiglia P, Cavalli A, Grieco P, et al. (2010) New insight into the mechanism of action of the temporin antimicrobial peptides. Biochemistry 49: 1477-1485.
61. Abbassi F, Lequin O, Piesse C, Goasdoué N, Foulon T, et al. (2010) Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide. J Biol Chem 285: 16880-16892.
62. Abbassi F, Galanth C, Amiche M, Saito K, Piesse C, et al. (2008) A Solution structure and model membrane interactions of temporins-SH, antimicrobial peptides from amphibian skin. A NMR spectroscopy and differential scanning calorimetry study. Biochemistry 47: 10513-10525.
63. Li P, Wohland T, Ho B, Ding JL, (2004) Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. J. Biol. Chem. 279: 50150-50156.
64. Bhunia A, Domadia PN, Bhattacharjya S, (2007) Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide. Biochim Biophys Acta 1768: 3282-3291.
65. Guntert P, (2004) Automated structure calcualtion with Cyana. Methods. Mol. Biol. 278: 353-378.
66. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM, (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR, J Biomol NMR. 8: 477-486.
67. Huang YJ, Powers R, Montelione GT, (2005) Protein NMR recall, precision, and F-measure scores (RPF scores): structure quality assessment measures based on information retrieval statistics, J. Am. Chem. Soc. 127: 1665-1674.